|Research & Innovation||For Patients With Unmet Needs||Contact Us Here|
Medlab Clinical Ltd's (ASX:MDC) Sean Hall tells Proactive that the company is building a cannabis-based drug that is the size of a nanoparticle.
Medlab Clinical and QUT are conducting a clinical trial to assess NRGBioticTM in the management of depression. The clinical trial follows on from two pilot studies which produced significant results of positive clinical benefits to patients administered magnesium orotate and NRGBioticTM respectively.
Ross Greenwood speaks to Medlab CEO Sean Hall about the first successful shipment of cannabis-based medicine, NanaBis. (NanaBisTM is an investigative new product containing 1:1 ratios of Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), delivery in a sub micron spray to the oro-buccal membrane.)
FASTBlend is a practitioner-only vanilla flavoured, whey protein powder that provides a healthy and convenient way to boost protein intake, along with essential vitamins and minerals.